OM Valuation
Outset Medical Inc
$
13.020
- Overview
- Forecast
- Valuation
- Earnings
OM Relative Valuation
OM's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, OM is overvalued; if below, it's undervalued.
Historical Valuation
Outset Medical Inc (OM) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.00 is considered Undervalued compared with the five-year average of -9.32. The fair price of Outset Medical Inc (OM) is between +Inf to +Inf according to relative valuation methord. Compared to the current price of 13.02 USD , Outset Medical Inc is Undervalued By Fair.
Relative Value
Fair Zone
+Inf-+Inf
Current Price：13.02
Fair
Undervalued
-4.85
PE
1Y
3Y
5Y
Trailing
Forward
-3.69
EV/EBITDA
Outset Medical Inc. (OM) has a current EV/EBITDA of -3.69. The 5-year average EV/EBITDA is -8.65. The thresholds are as follows: Strongly Undervalued below -22.26, Undervalued between -22.26 and -15.46, Fairly Valued between -1.85 and -15.46, Overvalued between -1.85 and 4.96, and Strongly Overvalued above 4.96. The current Forward EV/EBITDA of -3.69 falls within the Historic Trend Line -Fairly Valued range.
-3.38
EV/EBIT
Outset Medical Inc. (OM) has a current EV/EBIT of -3.38. The 5-year average EV/EBIT is -7.59. The thresholds are as follows: Strongly Undervalued below -19.37, Undervalued between -19.37 and -13.48, Fairly Valued between -1.70 and -13.48, Overvalued between -1.70 and 4.18, and Strongly Overvalued above 4.18. The current Forward EV/EBIT of -3.38 falls within the Historic Trend Line -Fairly Valued range.
1.72
PS
Outset Medical Inc. (OM) has a current PS of 1.72. The 5-year average PS is 9.76. The thresholds are as follows: Strongly Undervalued below -8.77, Undervalued between -8.77 and 0.49, Fairly Valued between 19.03 and 0.49, Overvalued between 19.03 and 28.29, and Strongly Overvalued above 28.29. The current Forward PS of 1.72 falls within the Historic Trend Line -Fairly Valued range.
0.00
P/OCF
Outset Medical Inc. (OM) has a current P/OCF of 0.00. The 5-year average P/OCF is -7.51. The thresholds are as follows: Strongly Undervalued below -24.77, Undervalued between -24.77 and -16.14, Fairly Valued between 1.12 and -16.14, Overvalued between 1.12 and 9.75, and Strongly Overvalued above 9.75. The current Forward P/OCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.
0.00
P/FCF
Outset Medical Inc. (OM) has a current P/FCF of 0.00. The 5-year average P/FCF is -8.12. The thresholds are as follows: Strongly Undervalued below -25.29, Undervalued between -25.29 and -16.70, Fairly Valued between 0.46 and -16.70, Overvalued between 0.46 and 9.05, and Strongly Overvalued above 9.05. The current Forward P/FCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.
Outset Medical Inc (OM) has a current Price-to-Book (P/B) ratio of 1.49. Compared to its 3-year average P/B ratio of 2.47 , the current P/B ratio is approximately -39.69% higher. Relative to its 5-year average P/B ratio of 3.59, the current P/B ratio is about -58.48% higher. Outset Medical Inc (OM) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of -101.73%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -64.43% , the current FCF yield is about -100.00% lower.
1.49
P/B
Median3y
2.47
Median5y
3.59
-30.97
FCF Yield
Median3y
-101.73
Median5y
-64.43
Competitors Valuation Multiple
The average P/S ratio for OM's competitors is 4.76, providing a benchmark for relative valuation. Outset Medical Inc Corp (OM) exhibits a P/S ratio of , which is -100.00% above the industry average. Given its robust revenue growth of 14.72%, this premium appears unsustainable.
Performance Decomposition
1Y
3Y
5Y
Market capitalization of OM increased by 59.37% over the past 1 year. The primary factor behind the change was an decrease in P/E Change from -0.52 to -1.03.
The secondary factor is the Revenue Growth, contributed 14.72%to the performance.
Overall, the performance of OM in the past 1 year is driven by P/E Change. Which is more unsustainable.
People Also Watch
NVDA
NVIDIA Corp
180.510
USD
-1.45%
MSFT
Microsoft Corp
527.600
USD
-0.31%
AMZN
Amazon.com Inc
223.620
USD
+0.97%
TSLA
Tesla Inc
341.730
USD
+0.26%
META
Meta Platforms Inc
785.300
USD
-0.59%
GOOGL
Alphabet Inc
203.310
USD
-0.01%
AAPL
Apple Inc
232.100
USD
+1.07%
GOOG
Alphabet Inc
204.360
USD
+0.10%
WMT
Walmart Inc
101.675
USD
-1.88%
AVGO
Broadcom Inc
309.270
USD
-1.14%
FAQ
Is Outset Medical Inc (OM) currently overvalued or undervalued?
Outset Medical Inc (OM) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.00 is considered Undervalued compared with the five-year average of -9.32. The fair price of Outset Medical Inc (OM) is between +Inf to +Inf according to relative valuation methord. Compared to the current price of 13.02 USD , Outset Medical Inc is Undervalued By Fair .
What is Outset Medical Inc (OM) fair value?
How does OM's valuation metrics compare to the industry average?
What is the current P/B ratio for Outset Medical Inc (OM) as of Aug 13 2025?
What is the current FCF Yield for Outset Medical Inc (OM) as of Aug 13 2025?
What is the current Forward P/E ratio for Outset Medical Inc (OM) as of Aug 13 2025?